Le Lézard
Classified in: Science and technology, Business
Subjects: EARNINGS, Conference Call, Webcast, Advisory

MSCI Schedules Earnings Call to Review First Quarter 2020 Results

MSCI Inc. (NYSE:MSCI), a leading provider of critical decision support tools and services for the global investment community, announced today it will release its results for the first quarter 2020 on Tuesday, April 28, 2020. A copy of the earnings release, as well as a quarterly update, will be made available on MSCI's Investor Relations homepage.

MSCI's senior management will review the first quarter 2020 results on Tuesday, April 28, 2020 at 11:00 AM Eastern Time. To listen to the live event, visit the events and presentations section of MSCI's Investor Relations homepage, http://ir.msci.com/events.cfm, or dial 1-877-376-9931 conference ID: 4073059 within the United States. International callers dial 1-720-405-2251 conference ID: 4073059. The teleconference will also be webcast with an accompanying slide presentation which can be accessed through MSCI's Investor Relations website.

An audio recording of the conference call will be available in the events and presentations section of MSCI's Investor Relations website, http://ir.msci.com/events.cfm, beginning approximately two hours after the conclusion of the live event for 12 months after the call. Through May 5, 2020, the recording will also be available by dialing 1-855-859-2056 conference ID: 4073059 within the United States or 1-404-537-3406 conference ID: 4073059 for international callers.

About MSCI Inc.

MSCI is a leading provider of critical decision support tools and services for the global investment community. With over 45 years of expertise in research, data and technology, we power better investment decisions by enabling clients to understand and analyze key drivers of risk and return and confidently build more effective portfolios. We create industry-leading, research-enhanced solutions that clients use to gain insight into and improve transparency across the investment process.

To learn more, please visit www.msci.com. MSCI#IR

These press releases may also interest you

at 08:05
Silverback Therapeutics ("Silverback"), a biopharmaceutical company advancing a pipeline of therapies that are systemically delivered, but locally active, today announced the appointment of Vickie L. Capps as director and audit committee chair....

at 08:05
Zebra Technologies Corporation , an innovator at the edge of the enterprise with solutions and partners that enable businesses to gain a performance edge, today launched Zebra MotionWorks® Proximity. The solution offers proximity sensing with...

at 08:05
Synedgen, a biotechnology company using glycochemistry to develop drugs that enhance and mimic the innate immune system, today announced that it has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) to market its Synvaza...

at 08:05
Omega Therapeutics, a genomic medicines company, today announced that it will deliver a corporate presentation at BIO Digital, the virtual format of the BIO International Convention, to be held June 8-12, 2020. Omega's transformative development...

at 08:05
OBIO's Health to Business Bridgetm Program (H2BB) prepares new hires for careers in Ontario's health science industry, helping companies build for the future in an innovative sector poised for growth. As we all work to combat the impact of...

at 08:05
Data-driven food allergy diagnostics company, AllerGenis LLC, today announced its activities at the European Academy of Allergy and Clinical Immunology (EAACI) Digital Congress 2020, being held virtually from June 6th through 8th. AllerGenis will...

News published on 8 april 2020 at 08:00 and distributed by: